Loading…
View analytic
Friday, November 27 • 10:30am - 12:00pm
The Role of Innovation in Addressing Antimicrobial Resistance / Le rôle de l'innovation dans la lutte contre la résistance aux antimicrobiens

Log in to save this to your schedule and see who's attending!

Organizer: Industry Canada

Antimicrobial resistance (AMR) is a global problem with efforts underway by individual countries, and by the G7 and WHO, to address the issues.  

As global efforts advance, Canada must examine the challenges and opportunities in research and development around AMR.  The purpose of this panel is to open the Canadian conversation around innovation:  what is Canada currently doing and what are the considerations for moving forward both domestically and internationally. 

Panelists from government and industry will discuss the current efforts underway globally and in Canada on AMR, and the role that innovation and partnerships in the health research community and industry will need to play to address the problems.



Moderators
avatar for Roman Szumski

Roman Szumski

Vice-President of Life Sciences, NRC
Dr. Roman Szumski joined NRC in July 2005 as Vice-President of Life Sciences. A medical doctor and pathologist by training, Dr. Szumski is recognized as a visionary leader and an innovative manager with unique experience in building strategic public-private sector partnerships in... Read More →

Speakers
avatar for Mr. Patrice Allibert

Mr. Patrice Allibert

CEO, GenePOC
Dr. Allibert holds a PhD in molecular biology for the University of Grenoble, France, and has more than 25 years of experience within the molecular diagnostic and vaccine industry. He has acted as an expert for the European Community and is now a member of the board of the Institute... Read More →
avatar for Brigitte Nolet

Brigitte Nolet

Hoffmann-La Roche Ltd. Basel Switzerland, Head of Global Public Policy
Brigitte Nolet joined the Roche Global Health Policy team as the Senior International Public Policy Manager for Oncology in January 2014, leading to her role as Head of Global Health Policy in April 2014. She previously worked as Director of Government Relations and Health Policy... Read More →
avatar for Dr. Marc Ouellette

Dr. Marc Ouellette

Scientific Director, CIHR
Dr. Marc Ouellette obtained his Bachelor of Science (Honours) in Biochemistry at Ottawa University and received his PhD at Laval University on antibiotic resistance in bacteria. His postdoctoral studies were done under the mentorship of Pr. Piet Borst of the Netherlands Cancer Institute... Read More →
avatar for Sameeh Salama

Sameeh Salama

Vice President, Business Development, NAEJA Pharmaceutical Inc.
Sameeh M. Salama, Ph.D. is the Vice President of Business Development at NAEJA Pharmaceutical Inc. His responsibilities include all activities related to in-licensing and out-licensing of research projects, strategic planning, project design and monitoring, as well as contract research... Read More →
MA

Ms. Angela Wittlesberger

Scientific Officer, Innovative Medicines Initiative (IMI)
Angela Wittelsberger, Ph.D., scientific officer at the Innovative Medicines Initiative (IMI), is mostly involved in the planning and organisation of the early stages of new IMI projects, notably the interaction with industry partners and definition of new call topics, and communication... Read More →
avatar for Dr. Gerry Wright

Dr. Gerry Wright

Director of the Michel G. DeGroote Institute for Infectious Disease Research, McMaster University
Dr. Gerry Wright is the Director of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University (2007-present). He is Professor in the Department of Biochemistry and Biomedical Sciences and Associate member of the Departments of Chemistry and Chemical... Read More →


Friday November 27, 2015 10:30am - 12:00pm
Richelieu (level C)

Attendees (0)




Twitter Feed